Reader in Chemical & Structural Biology, School of Life Sciences, University of Dundee
Alessio Ciulli is Reader in Chemical & Structural Biology, School of Life Sciences, University of Dundee. Previously he was a BBSRC David Phillips Fellow at the University of Cambridge within the Department of Chemistry and a Fellow of Christ's College.
Alessio graduated Magna Cum Laude in Chemistry from the University of Florence in 2002. His final year Laurea project was in computational drug design and NMR spectroscopy with Professor Ivan Bertini at the Magnetic Resonance Center (CERM).
In 2002 he was awarded a Gates Cambridge Scholarship to study at Cambridge under the supervision of Professor Chris Abell. His PhD research, in collaboration with Astex Therapeutics, concerned with studying weak protein-ligand interactions using biophysical and structural methods and investigated the dehydrogenase involved in vitamin B5 biosynthesis as a model system.
In 2006 he was awarded a College Research Fellowship to conduct post-doctoral research on fragment-based drug design, within the framework of two international consortia to develop new drugs against tuberculosis funded by the Bill & Melinda Gates Foundation and the European Union FP6, jointly directed by Professor Abell and Professor Sir Tom Blundell.
After a short postdoctoral tenure as a Human Frontier Science Programme Fellow with Professor Craig Crews at Yale University in 2009, working on small molecule PROTACS, Alessio was awarded a BBSRC David Phillips Fellowship to return to Cambridge and started his independent research career in January 2010.